腫瘤醫療龍頭海吉亞(6078.HK)再創歷史新高 市值超600億港元
格隆匯6月22日丨海吉亞醫療(6078.HK)繼續上漲,盤中最高漲近9%至103.8港元,再創歷史新高,市值超600億港元。上市即將滿1年的海吉亞醫療動作不斷,繼4月宣佈計劃耗資17.35億元收購蘇州永鼎醫院後,5月宣佈計劃以不超過6.416億元收購賀州廣濟醫院。野村日前發報吿稱,海吉亞醫療早前公佈的收購已於5月完成,料全年可提供4.94億元人民幣收入貢獻。隨着順利的內部整合、料被收購醫院的牀位使用率及盈利能力於2022年至2025年會有明顯改善。加上海吉亞醫療持續增加自建醫院,長期增長具透明度;故將其目標價相應自101.7港元上調至117.4港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.